Ameritas Advisory Services’s Terns Pharmaceuticals TERN Stock Holding History

Ameritas Advisory Services’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-96	Closed	-$5.06K	–	2111
2026 Q1	$5.06K	Buy	+96	New	+$3.94K	﹤0.01%	985

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Advisory Services's TERN Position: Q2 2026 in Review

Ameritas Advisory Services sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 96 shares — an estimated $5.06K sold.

Ameritas Advisory Services first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $5.06K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Ameritas Advisory Services reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Ameritas Advisory Services sold 96 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.06K.
Ameritas Advisory Services first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Ameritas Advisory Services's Terns Pharmaceuticals position peaked at $5.06K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.